TITLE

Botulinum toxin for drooling in cerebral palsy

PUB. DATE
April 2007
SOURCE
Archives of Disease in Childhood;Apr2007, Vol. 92 Issue 4, p338
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article examines the effectiveness of the drug botulinum toxin A in treating cerebral palsy in children. The drug was injected under midazolam and nitrous oxide sedation with ultrasound guidance. A significant reduction in drooling severity scores was found. The quality of life scores were improved significantly.
ACCESSION #
25020986

 

Related Articles

  • Medical treatments. Cutts, Steven; Edwards, Alison; Myers, Graham // GP: General Practitioner;1/28/2002, p54 

    Focuses on the use of botulinum toxin in treating cerebral palsy. Impact on the relaxation; Safety in using the medicine; Method of administration.

  • Botulinum toxin in the cerebral palsies. Neville, Brian // BMJ: British Medical Journal (International Edition);12/10/94, Vol. 309 Issue 6968, p1526 

    Examines the application of botulinum toxin in the treatment of cerebral palsies. Details of cerebral palsies; Treatment of cerebral palsies; Comparison between cerebral palsies and focal dystonias.

  • The Baclofen Pump. Albright, A. Leland // Exceptional Parent;Jun99, Vol. 29 Issue 6, p46 

    Focuses on the use of Intrathecal Baclofen (ITB) as treatment for children with cerebral palsy. Why many children with cerebral palsy develop spasticity; How ITB is administered; How ITB is implanted. INSET: The ITB Experience, by Larry McClaugherty.

  • Nerve and Muscle.  // Current Medical Literature: Neurology;2003, Vol. 19 Issue 2, p49 

    Focuses on the effect of botulinum toxin A injections to the lower limbs on cerebral palsy. Gait analysis; Improvement in fine motor function.

  • Face Facts.  // Prevention;Sep2011, Vol. 63 Issue 9, p53 

    The article discusses a study which found that people who have used Botox are less likely to interpret the expressions of other people.

  • Deadly botulism toxin kept under wraps.  // New Scientist;10/19/2013, Vol. 220 Issue 2939, p16 

    The article reports that Stephen Arnon and colleagues at the California Department of Public Health discovered the most lethal toxin around, a novel type of botulinum, which they shared only reacted weakly with a few of the standard antibodies on mice.

  • Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Albavera-Hernández, Cidronio; Rodríguez, Jorge M.; Idrovo, Alvaro J. // Clinical Rehabilitation;May2009, Vol. 23 Issue 5, p394 

    Objective: To assess the safety of botulinum toxin type A for children with cerebral palsy using data from randomized clinical trials. Data sources: A search was conducted of MEDLINE database for the period January 1990 to February 2008. A complementary search was carried out of references from...

  • Use of Botulinum Toxin Type A in Pediatric Patients With Cerebral Palsy: A Three-Center... Gormley, Mark E.; Gaebler-Spira, Deborah; Delgado, Mauricio R. // Journal of Child Neurology;Feb2001, Vol. 16 Issue 2, p113 

    Examines the dosing of botulinum toxin type A treatments in a retrospective chart review of children with cerebral palsy at three major treatment centers. Clinical features of cerebral palsy; Patterns of botulinum toxin type A use in the clinical setting; Formulation differences between the...

  • Dermasurgery complications run the gamut. Jesitus, John // Dermatology Times;Oct2005, Vol. 26 Issue 10, p35 

    Focuses on the issue regarding the treatment of botulinum toxin in the U.S. Key to resolving these problems; Demand of immediate and decisive action for post-surgical hematomas; Role of the physician who performed the surgery.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics